[HTML][HTML] 2017–2018 scientific advances in thoracic oncology: small cell lung cancer

S Zimmerman, A Das, S Wang, R Julian… - Journal of Thoracic …, 2019 - Elsevier
SCLC remains an aggressive, deadly cancer with only modest effect on survival from
standard chemotherapy. However, with the advent of immunotherapy and comprehensive …

2017-2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer.

S Zimmerman, A Das, S Wang, R Julian… - Journal of thoracic …, 2019 - folia.unifr.ch
English SCLC remains an aggressive, deadly cancer with only modest effect on survival
from standard chemotherapy. However, with the advent of immunotherapy and …

2017-2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer

S Zimmerman, A Das, S Wang, R Julian… - J. Thorac …, 2019 - kups.ub.uni-koeln.de
SCLC remains an aggressive, deadly cancer with only modest effect on survival from
standard chemotherapy. However, with the advent of immunotherapy and comprehensive …

2017–2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer

S Zimmerman, A Das, S Wang, R Julian, L Gandhi… - Journal of Thoracic …, 2019 - jto.org
SCLC remains an aggressive, deadly cancer with only modest effect on survival from
standard chemotherapy. However, with the advent of immunotherapy and comprehensive …

2017-2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer

S Zimmerman, A Das, S Wang… - Journal of thoracic …, 2019 - pubmed.ncbi.nlm.nih.gov
SCLC remains an aggressive, deadly cancer with only modest effect on survival from
standard chemotherapy. However, with the advent of immunotherapy and comprehensive …

2017-2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer.

S Zimmerman, A Das, S Wang, R Julian… - Journal of Thoracic …, 2019 - europepmc.org
SCLC remains an aggressive, deadly cancer with only modest effect on survival from
standard chemotherapy. However, with the advent of immunotherapy and comprehensive …

2017-2018 Scientific Advances in Thoracic Oncology: Small Cell Lung Cancer.

S Zimmerman, A Das, S Wang, R Julian… - Journal of thoracic …, 2019 - sonar.ch
English SCLC remains an aggressive, deadly cancer with only modest effect on survival
from standard chemotherapy. However, with the advent of immunotherapy and …